Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000256350 is a human pseudogene annotated as 'pseudogene similar to part of anoctamin 10.' Pseudogenes typically contain high sequence homology to their parent genes—in this case, Anoctamin 10 (ANO10), a calcium-activated chloride channel implicated in spinocerebellar ataxia[1][5]. Pseudogenes may arise by duplication or retrotransposition but suffer mutations or loss of regulatory sequences; thus, they may lack the ability to express functional proteins[4][6]. While some pseudogenes have been assigned regulatory roles or suggested as disease biomarkers, most remain nonfunctional and are not considered therapeutic targets[2]. No structure, function, or disease relevance has been directly assigned to ENSG00000256350, and it is not recognized as a canonical molecular target for therapy or research. Key points: - ENSG00000256350 is a pseudogene, not a protein-coding gene, receptor, ion channel, or enzyme. - No functional, disease, or drug-related information associated with it. - Not suitable as a canonical or therapeutic target; therefore, entries like drugs, mechanism, and biomarkers are null.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of Anoctamin 10 (ENSG00000256350).